These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26543681)

  • 1. The Role of Chemokines in Fibrotic Wound Healing.
    Ding J; Tredget EE
    Adv Wound Care (New Rochelle); 2015 Nov; 4(11):673-686. PubMed ID: 26543681
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Features of Hypertrophic Scars After Thermal Injury: Is There a Biologic Basis for Laser Therapy?
    Schaffrick L; Ding J; Kwan P; Tredget EE
    Adv Wound Care (New Rochelle); 2022 Apr; 11(4):163-178. PubMed ID: 34663086
    [No Abstract]   [Full Text] [Related]  

  • 3. The Biology of Extracellular Matrix Proteins in Hypertrophic Scarring.
    Eremenko E; Ding J; Kwan P; Tredget EE
    Adv Wound Care (New Rochelle); 2022 May; 11(5):234-254. PubMed ID: 33913776
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis.
    Honardoust D; Kwan P; Momtazi M; Ding J; Tredget EE
    Methods Mol Biol; 2013; 1037():203-31. PubMed ID: 24029937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring.
    Xue M; Jackson CJ
    Adv Wound Care (New Rochelle); 2015 Mar; 4(3):119-136. PubMed ID: 25785236
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.
    Rees PA; Greaves NS; Baguneid M; Bayat A
    Adv Wound Care (New Rochelle); 2015 Nov; 4(11):687-703. PubMed ID: 26543682
    [No Abstract]   [Full Text] [Related]  

  • 7. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.
    Slemp AE; Kirschner RE
    Curr Opin Pediatr; 2006 Aug; 18(4):396-402. PubMed ID: 16914994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo.
    Ding J; Ma Z; Liu H; Kwan P; Iwashina T; Shankowsky HA; Wong D; Tredget EE
    Wound Repair Regen; 2014; 22(5):622-30. PubMed ID: 25139227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keloids and hypertrophic scars: update and future directions.
    Huang C; Murphy GF; Akaishi S; Ogawa R
    Plast Reconstr Surg Glob Open; 2013 Jul; 1(4):e25. PubMed ID: 25289219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
    Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
    J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New views on the physiology of wound healing].
    Komarcević A; Pejakov L; Komarcević M
    Med Pregl; 2000; 53(9-10):479-83. PubMed ID: 11320729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar.
    Honardoust D; Varkey M; Hori K; Ding J; Shankowsky HA; Tredget EE
    Wound Repair Regen; 2011; 19(3):368-78. PubMed ID: 21518082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical Forces in Cutaneous Wound Healing: Emerging Therapies to Minimize Scar Formation.
    Barnes LA; Marshall CD; Leavitt T; Hu MS; Moore AL; Gonzalez JG; Longaker MT; Gurtner GC
    Adv Wound Care (New Rochelle); 2018 Feb; 7(2):47-56. PubMed ID: 29392093
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
    Wolfram D; Tzankov A; Pülzl P; Piza-Katzer H
    Dermatol Surg; 2009 Feb; 35(2):171-81. PubMed ID: 19215252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Nude Mouse Model of Hypertrophic Scarring Using Scratched Full Thickness Human Skin Grafts.
    Alrobaiea SM; Ding J; Ma Z; Tredget EE
    Adv Wound Care (New Rochelle); 2016 Jul; 5(7):299-313. PubMed ID: 27366591
    [No Abstract]   [Full Text] [Related]  

  • 20. The molecular mechanism of hypertrophic scar.
    Zhu Z; Ding J; Shankowsky HA; Tredget EE
    J Cell Commun Signal; 2013 Dec; 7(4):239-52. PubMed ID: 23504443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.